Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05727020Recruiting

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma

Role: collaborator

NCT07243262Recruiting

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)

Role: collaborator

NCT04305067Not ApplicableCompleted

PRECISE: Pancreatic Cancer and Exercise

Role: collaborator

NCT03616431Completed

Pancreatic Cancer Dietary Assessment Study

Role: collaborator

NCT05980221Not ApplicableUnknown

The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency (The DETECTION Study)

Role: collaborator

All 5 trials loaded